Charles River Laboratories (CRL)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	474,624	474,950	484,034	496,335	486,226	436,394	443,347	422,474	390,982	396,595	396,078	375,065	364,304	301,461	271,362	247,655	252,019	231,336	218,894	228,875
Revenue (ttm)	US$ in thousands	4,097,200	4,325,190	4,303,632	4,238,180	4,106,274	3,792,022	3,683,743	3,605,712	3,459,843	3,333,185	3,172,755	2,930,880	2,859,828	2,759,976	2,697,739	2,671,095	2,595,709	2,506,101	2,411,563	2,341,443
Net profit margin		11.58%	10.98%	11.25%	11.71%	11.84%	11.51%	12.04%	11.72%	11.30%	11.90%	12.48%	12.80%	12.74%	10.92%	10.06%	9.27%	9.71%	9.23%	9.08%	9.77%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $474,624K ÷ $4,097,200K
= 11.58%

The net profit margin of Charles River Laboratories has been relatively stable over the past five years, ranging from 9.06% to 12.80%. The company's net profit margin measures the percentage of revenue that translates into profit after all expenses are deducted. In the most recent quarter, the net profit margin was 11.58%, indicating that the company retained around 11.58 cents of every dollar in revenue as profit.

The trend shows a slight decrease in the net profit margin in the most recent quarter compared to the previous quarter's 11.84%. However, it is important to note that the company has maintained a healthy net profit margin above 10% consistently, reflecting efficient cost management and profitability. Overall, Charles River Laboratories' ability to generate profit from its operations is reflected in its stable and positive net profit margin performance.